Variant report
Variant | nsv535684 |
---|---|
Chromosome Location | chr2:48796170-49443587 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3129)
- CpG islands (count:3544)
- Chromatin interactive region (count:116)
- LncRNA region (count:15)
- Mature miRNA region (count: 1)
- miRNA target sites (count:1)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr2:48827388-48827716 | K562 | blood: | n/a | chr2:48827687-48827703 |
2 | ARID3A | chr2:48832723-48833286 | K562 | blood: | n/a | n/a |
3 | ARID3A | chr2:48800039-48800306 | HepG2 | liver: | n/a | n/a |
4 | ARID3A | chr2:48816377-48816687 | HepG2 | liver: | n/a | n/a |
5 | ARID3A | chr2:48816337-48816665 | K562 | blood: | n/a | n/a |
6 | ARID3A | chr2:49173731-49173967 | K562 | blood: | n/a | n/a |
7 | ARID3A | chr2:49173646-49173953 | HepG2 | liver: | n/a | n/a |
8 | ARID3A | chr2:48834779-48835112 | K562 | blood: | n/a | n/a |
9 | ARID3A | chr2:49154095-49154817 | HepG2 | liver: | n/a | n/a |
10 | ARID3A | chr2:48850023-48850151 | K562 | blood: | n/a | n/a |
11 | ATF1 | chr2:48930875-48931104 | K562 | blood: | n/a | n/a |
12 | ATF1 | chr2:48904722-48905003 | K562 | blood: | n/a | n/a |
13 | ATF1 | chr2:48878247-48878500 | K562 | blood: | n/a | n/a |
14 | ATF1 | chr2:48832810-48833265 | K562 | blood: | n/a | n/a |
15 | ATF2 | chr2:48812780-48813200 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | ATF2 | chr2:49173687-49173977 | GM12878 | blood: | n/a | n/a |
17 | ATF3 | chr2:48834690-48835094 | K562 | blood: | n/a | n/a |
18 | ATF3 | chr2:48832914-48833249 | K562 | blood: | n/a | n/a |
19 | BACH1 | chr2:49367907-49368045 | K562 | blood: | n/a | n/a |
20 | BACH1 | chr2:49164205-49164317 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | BACH1 | chr2:48953356-48953556 | K562 | blood: | n/a | n/a |
22 | BATF | chr2:49368436-49368647 | GM12878 | blood: | n/a | chr2:49368533-49368544 |
23 | BATF | chr2:48977026-48977296 | GM12878 | blood: | n/a | chr2:48977147-48977158 chr2:48977148-48977158 |
24 | BATF | chr2:48976989-48977239 | GM12878 | blood: | n/a | chr2:48977147-48977158 chr2:48977148-48977158 |
25 | BATF | chr2:49255280-49255569 | GM12878 | blood: | n/a | n/a |
26 | BATF | chr2:49255320-49255581 | GM12878 | blood: | n/a | n/a |
27 | BCL11A | chr2:49307852-49308039 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | BCL11A | chr2:49255252-49255620 | GM12878 | blood: | n/a | n/a |
29 | BCL11A | chr2:49356233-49356526 | GM12878 | blood: | n/a | n/a |
30 | BCL11A | chr2:49255222-49255584 | GM12878 | blood: | n/a | n/a |
31 | BCL3 | chr2:49032320-49032504 | GM12878 | blood: | n/a | n/a |
32 | BCL3 | chr2:49168897-49169140 | GM12878 | blood: | n/a | n/a |
33 | BHLHE40 | chr2:48834871-48834971 | K562 | blood: | n/a | n/a |
34 | BHLHE40 | chr2:49437340-49437444 | HepG2 | liver: | n/a | n/a |
35 | BHLHE40 | chr2:48874042-48874175 | K562 | blood: | n/a | n/a |
36 | BHLHE40 | chr2:49014802-49015192 | K562 | blood: | n/a | chr2:49014897-49014918 chr2:49014902-49014911 chr2:49014901-49014914 chr2:49014903-49014912 chr2:49014903-49014912 |
37 | BHLHE40 | chr2:49173756-49173890 | K562 | blood: | n/a | n/a |
38 | BHLHE40 | chr2:48827501-48827675 | GM12878 | blood: | n/a | n/a |
39 | BHLHE40 | chr2:49255201-49255748 | GM12878 | blood: | n/a | n/a |
40 | BHLHE40 | chr2:48832874-48833229 | K562 | blood: | n/a | n/a |
41 | BHLHE40 | chr2:48942448-48942774 | K562 | blood: | n/a | n/a |
42 | BRCA1 | chr2:49348882-49348887 | GM12878 | blood: | n/a | n/a |
43 | BRCA1 | chr2:49307903-49308246 | H1-hESC | embryonic stem cell: | n/a | n/a |
44 | CBX3 | chr2:48832720-48833279 | K562 | blood: | n/a | n/a |
45 | CBX3 | chr2:48934682-48934922 | K562 | blood: | n/a | n/a |
46 | CBX3 | chr2:48834298-48835187 | HCT-116 | colon: | n/a | n/a |
47 | CBX3 | chr2:48832078-48833351 | K562 | blood: | n/a | n/a |
48 | CBX3 | chr2:48840504-48840934 | K562 | blood: | n/a | n/a |
49 | CBX3 | chr2:48834627-48835227 | K562 | blood: | n/a | n/a |
50 | CBX3 | chr2:48834288-48835170 | HCT-116 | colon: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:48806774-48806824 | HCT-116 | colon: | n/a |
2 | chr2:48842430-48842480 | SK-N-SH_RA | brain: | n/a |
3 | chr2:48844916-48844966 | Jurkat | blood: | n/a |
4 | chr2:49271470-49271520 | IMR90 | lung: | fetal |
5 | chr2:48800297-48800347 | SK-N-MC | brain: | n/a |
6 | chr2:48982754-48982804 | AoSMC | blood vessel: | n/a |
7 | chr2:48806774-48806824 | HCT-116 | colon: | n/a |
8 | chr2:48842430-48842480 | SK-N-SH_RA | brain: | n/a |
9 | chr2:48844916-48844966 | Jurkat | blood: | n/a |
10 | chr2:49271470-49271520 | IMR90 | lung: | fetal |
11 | chr2:48800297-48800347 | SK-N-MC | brain: | n/a |
12 | chr2:48982754-48982804 | AoSMC | blood vessel: | n/a |
13 | chr2:48982683-48982733 | NB4 | blood: | n/a |
14 | chr2:48950153-48950203 | NHBE | bronchial: | n/a |
15 | chr2:49037725-49037775 | PANC-1 | pancreas: | n/a |
16 | chr2:49115406-49115456 | GM12891 | blood: | n/a |
17 | chr2:48809499-48809549 | T-47D | breast: | n/a |
18 | chr2:49143334-49143384 | SK-N-MC | brain: | n/a |
19 | chr2:49271470-49271520 | K562 | blood: | n/a |
20 | chr2:49382159-49382209 | HRPEpiC | eye: | n/a |
21 | chr2:48982957-48983007 | HNPCEpiC | eye: | n/a |
22 | chr2:48920986-48921036 | Hepatocyte | liver: | n/a |
23 | chr2:48844728-48844778 | ECC-1 | luminal epithelium: | n/a |
24 | chr2:48977089-48977139 | MCF-7 | breast: | n/a |
25 | chr2:49115406-49115456 | T-47D | breast: | n/a |
26 | chr2:48950153-48950203 | HEK293 | kidney: | embryo |
27 | chr2:49382159-49382209 | U87 | brain: | n/a |
28 | chr2:48813184-48813234 | Hela-S3 | cervix: | n/a |
29 | chr2:48983189-48983239 | PFSK-1 | brain: | n/a |
30 | chr2:49089947-49089997 | CMK | blood: | n/a |
31 | chr2:49380959-49381009 | HMEC | breast: | n/a |
32 | chr2:48980605-48980655 | GM12892 | blood: | n/a |
33 | chr2:48848421-48848471 | SK-N-SH | brain: | n/a |
34 | chr2:48962273-48962323 | Caco-2 | colon: | n/a |
35 | chr2:48983178-48983228 | H1-hESC | embryonic stem cell: | embryo |
36 | chr2:48982957-48983007 | HCM | heart: | n/a |
37 | chr2:48842061-48842111 | K562 | blood: | n/a |
38 | chr2:48842430-48842480 | HIPEpiC | eye: | n/a |
39 | chr2:48806774-48806824 | GM12891 | blood: | n/a |
40 | chr2:48828358-48828408 | MCF-7 | breast: | n/a |
41 | chr2:48927520-48927570 | T-47D | breast: | n/a |
42 | chr2:48828358-48828408 | HCM | heart: | n/a |
43 | chr2:48983178-48983228 | AG04449 | skin: | fetal |
44 | chr2:49143534-49143584 | GM12892 | blood: | n/a |
45 | chr2:48956876-48956926 | NH-A | brain: | n/a |
46 | chr2:48982754-48982804 | Hepatocyte | liver: | n/a |
47 | chr2:48844763-48844813 | GM12892 | blood: | n/a |
48 | chr2:48796151-48796201 | AG10803 | skin: | n/a |
49 | chr2:48796213-48796263 | HEEpiC | esophagus: | n/a |
50 | chr2:49271470-49271520 | CMK | blood: | n/a |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:48827218..48827809-chr2:49717926..49718495,2 | MCF-7 | breast: | |
2 | chr2:49114963..49117141-chr2:49121572..49123521,3 | K562 | blood: | |
3 | chr2:48837425..48839347-chr2:48846973..48850503,3 | K562 | blood: | |
4 | chr2:48947110..48949799-chr2:48950949..48954085,3 | K562 | blood: | |
5 | chr2:49114963..49117141-chr2:49121572..49123521,3 | K562 | blood: | |
6 | chr2:49080769..49083086-chr2:49086686..49089047,2 | MCF-7 | breast: | |
7 | chr2:48826097..48828718-chr2:49093582..49095780,2 | K562 | blood: | |
8 | chr2:48918966..48921288-chr2:48922320..48925277,2 | K562 | blood: | |
9 | chr2:49009264..49011801-chr2:49015723..49017934,2 | K562 | blood: | |
10 | chr2:48901897..48904285-chr2:48937962..48940671,2 | K562 | blood: | |
11 | chr2:48827557..48828940-chr2:49173265..49174447,4 | MCF-7 | breast: | |
12 | chr2:48996460..48999048-chr2:49041792..49043593,2 | MCF-7 | breast: | |
13 | chr2:49121216..49123118-chr2:49126253..49127804,2 | MCF-7 | breast: | |
14 | chr2:48793447..48794436-chr2:48816095..48816687,2 | K562 | blood: | |
15 | chr2:48996460..48999048-chr2:49041792..49043593,2 | MCF-7 | breast: | |
16 | chr2:48904136..48905986-chr2:48910089..48911674,2 | K562 | blood: | |
17 | chr2:49013902..49015709-chr2:49018982..49021031,2 | MCF-7 | breast: | |
18 | chr2:49022010..49024033-chr2:49025700..49028628,2 | MCF-7 | breast: | |
19 | chr2:49022703..49025373-chr2:49029077..49031757,2 | K562 | blood: | |
20 | chr2:49067039..49069722-chr2:49070584..49073190,2 | K562 | blood: | |
21 | chr2:49067039..49069722-chr2:49070584..49073190,2 | K562 | blood: | |
22 | chr2:48772382..48773067-chr2:48815926..48816979,3 | K562 | blood: | |
23 | chr2:49173283..49174235-chr2:49717706..49718797,6 | MCF-7 | breast: | |
24 | chr2:48955353..48957599-chr2:48959365..48961603,2 | MCF-7 | breast: | |
25 | chr2:49001281..49003714-chr2:49013829..49016593,2 | MCF-7 | breast: | |
26 | chr2:48974519..48977429-chr2:49021339..49023541,3 | MCF-7 | breast: | |
27 | chr2:49001281..49003714-chr2:49013829..49016593,2 | MCF-7 | breast: | |
28 | chr2:49173374..49174210-chr2:49199575..49200403,3 | MCF-7 | breast: | |
29 | chr2:49226004..49228152-chr2:49232900..49234588,2 | MCF-7 | breast: | |
30 | chr2:49081319..49083197-chr2:49107259..49109037,2 | MCF-7 | breast: | |
31 | chr2:49260442..49262914-chr2:49263129..49265285,2 | K562 | blood: | |
32 | chr2:48338188..48338961-chr2:48816027..48816580,2 | MCF-7 | breast: | |
33 | chr2:49108913..49110824-chr2:49114186..49115949,2 | MCF-7 | breast: | |
34 | chr2:49182201..49184078-chr2:49187654..49190318,2 | K562 | blood: | |
35 | chr2:49013902..49015709-chr2:49018982..49021031,2 | MCF-7 | breast: | |
36 | chr2:49009264..49011801-chr2:49015723..49017934,2 | K562 | blood: | |
37 | chr2:49186669..49188869-chr2:49189204..49191153,2 | K562 | blood: | |
38 | chr2:48947110..48950890-chr2:48950949..48954085,5 | K562 | blood: | |
39 | chr2:48822120..48826399-chr2:48830586..48834373,3 | K562 | blood: | |
40 | chr2:49139634..49141993-chr2:49154425..49156573,2 | K562 | blood: | |
41 | chr2:48845784..48847693-chr2:48848992..48850627,2 | K562 | blood: | |
42 | chr2:48899103..48900749-chr2:48945263..48947505,2 | MCF-7 | breast: | |
43 | chr2:48899103..48900749-chr2:48945263..48947505,2 | MCF-7 | breast: | |
44 | chr2:48837425..48839347-chr2:48846973..48850503,3 | K562 | blood: | |
45 | chr2:48999248..49001151-chr2:49005817..49007836,2 | K562 | blood: | |
46 | chr2:48938808..48941243-chr2:48942125..48945142,3 | K562 | blood: | |
47 | chr2:48764687..48766642-chr2:48801802..48803658,2 | MCF-7 | breast: | |
48 | chr2:49173523..49174048-chr2:50629252..50630106,2 | MCF-7 | breast: | |
49 | chr2:48976168..48977940-chr2:48995594..48997620,2 | MCF-7 | breast: | |
50 | chr2:49121216..49123118-chr2:49126253..49127804,2 | MCF-7 | breast: |
(count:15 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-STON1-GTF2A1L-1 | chr2:48996106-48996213 | XLOC_001466 |
2 | lnc-STON1-GTF2A1L-3 | chr2:49437434-49437440 | NONHSAT070638 |
3 | lnc-LHCGR-1 | chr2:48873569-48873753 | NONHSAT070627 |
4 | lnc-STON1-GTF2A1L-1 | chr2:48996106-48996213 | XLOC_001466 |
5 | lnc-LHCGR-1 | chr2:48874168-48874258 | NONHSAT070627 |
6 | lnc-STON1-GTF2A1L-1 | chr2:48996093-48996260 | NONHSAT070630 |
7 | lnc-STON1-GTF2A1L-1 | chr2:49003419-49003620 | NONHSAT070630 |
8 | lnc-LHCGR-1 | chr2:48859428-48860260 | NONHSAT070627 |
9 | lnc-STON1-GTF2A1L-1 | chr2:49003422-49003658 | XLOC_001466 |
10 | lnc-STON1-GTF2A1L-1 | chr2:49003419-49003658 | XLOC_001466 |
11 | lnc-LHCGR-1 | chr2:48895709-48895804 | NONHSAT070627 |
12 | lnc-LHCGR-1 | chr2:48859995-48860492 | NONHSAT070628 |
13 | lnc-STON1-GTF2A1L-3 | chr2:49436966-49437234 | NONHSAT070638 |
14 | lnc-FSHR-1 | chr2:49179431-49179679 | NONHSAT070635 |
15 | lnc-STON1-GTF2A1L-2 | chr2:49007741-49008034 | NONHSAT070633 |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-548ba | chr2:49286742-49286763 | MIMAT0031175 |
(count:1 , 50 per page) page:
1
No. | miRNA target gene | miRNA name | Chromosome Location | mirBase accession |
---|---|---|---|---|
1 | LHCGR | hsa-miR-148b-3p | chr2:48914407-48914429 |
Variant related genes | Relation type |
---|---|
FSHR | TF binding region |
STON1 | TF binding region |
GTF2A1L | TF binding region |
CTBP2P5 | TF binding region |
TCEB2P3 | TF binding region |
TPT1P11 | TF binding region |
LHCGR | TF binding region |
STON1-GTF2A1L | TF binding region |
FSHR | CpG island |
STON1 | CpG island |
GTF2A1L | CpG island |
CTBP2P5 | CpG island |
TCEB2P3 | CpG island |
TPT1P11 | CpG island |
LHCGR | CpG island |
STON1-GTF2A1L | CpG island |
ENSG00000242441 | chromatin interactions |
ENSG00000243244 | chromatin interactions |
ENSG00000162869 | chromatin interactions |
ENSG00000138039 | chromatin interactions |
ENSG00000170820 | chromatin interactions |
ENSG00000232285 | chromatin interactions |
ENSG00000068781 | chromatin interactions |
RNF219 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527835694 | chr2:48796170-48796171 | Weak transcription Flanking Active TSS Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs375192631 | chr2:48796189-48796190 | Weak transcription Flanking Active TSS Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531590368 | chr2:48796217-48796218 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187588443 | chr2:48796218-48796219 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140216510 | chr2:48796229-48796230 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549187749 | chr2:48796243-48796244 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75053980 | chr2:48796291-48796292 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537811225 | chr2:48796316-48796317 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150293144 | chr2:48796338-48796339 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549219227 | chr2:48796341-48796342 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543137952 | chr2:48796352-48796353 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192717829 | chr2:48796353-48796354 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs137937896 | chr2:48796354-48796355 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556328727 | chr2:48796364-48796365 | Weak transcription Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6732365 | chr2:48796407-48796408 | Weak transcription Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs369105085 | chr2:48796490-48796491 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567830698 | chr2:48796579-48796580 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149483418 | chr2:48796635-48796636 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143101683 | chr2:48796639-48796640 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138787682 | chr2:48796645-48796646 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540084092 | chr2:48796776-48796777 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565703328 | chr2:48796824-48796825 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113923154 | chr2:48796855-48796856 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74405734 | chr2:48796866-48796867 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142808723 | chr2:48796884-48796885 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564900505 | chr2:48796903-48796904 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540980317 | chr2:48796913-48796914 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6761796 | chr2:48796966-48796967 | Weak transcription Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs573320168 | chr2:48797078-48797079 | Weak transcription Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35106332 | chr2:48797140-48797141 | Weak transcription Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs527959481 | chr2:48797159-48797160 | Weak transcription Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116448317 | chr2:48797160-48797161 | Weak transcription Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7559073 | chr2:48797168-48797169 | Weak transcription Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs538514918 | chr2:48797169-48797170 | Weak transcription Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531601672 | chr2:48797213-48797214 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377589337 | chr2:48797226-48797227 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571216130 | chr2:48797251-48797252 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538366178 | chr2:48797252-48797253 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184581322 | chr2:48797258-48797259 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566192431 | chr2:48797264-48797265 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536830913 | chr2:48797275-48797276 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1851796 | chr2:48797290-48797291 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs576341739 | chr2:48797367-48797368 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187233401 | chr2:48797399-48797400 | Weak transcription Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74666215 | chr2:48797478-48797479 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200434090 | chr2:48797553-48797554 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576785367 | chr2:48797559-48797560 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541208015 | chr2:48797562-48797563 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs117810287 | chr2:48797563-48797564 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs139781469 | chr2:48797565-48797566 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 22522925 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:48759000-48827600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
2 | chr2:48767200-48807800 | Weak transcription | Aorta | Aorta |
3 | chr2:48773000-48808800 | Weak transcription | Right Ventricle | heart |
4 | chr2:48777200-48807800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr2:48779400-48800200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr2:48787800-48802200 | Weak transcription | Esophagus | oesophagus |
7 | chr2:48788200-48798200 | Weak transcription | Lung | lung |
8 | chr2:48788400-48799400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr2:48788400-48804600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr2:48788600-48812000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr2:48790000-48800000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr2:48793600-48796200 | Enhancers | Fetal Kidney | kidney |
13 | chr2:48793600-48796200 | Enhancers | Placenta | Placenta |
14 | chr2:48794000-48807800 | Weak transcription | Psoas Muscle | Psoas |
15 | chr2:48794200-48807800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
16 | chr2:48794400-48796200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
17 | chr2:48794400-48799600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
18 | chr2:48794400-48807800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
19 | chr2:48794400-48812000 | Weak transcription | H1 Cell Line | embryonic stem cell |
20 | chr2:48794400-48827200 | Weak transcription | NHDF-Ad | bronchial |
21 | chr2:48794600-48796400 | Enhancers | Placenta Amnion | Placenta Amnion |
22 | chr2:48794600-48811200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
23 | chr2:48794800-48796200 | Enhancers | Ovary | ovary |
24 | chr2:48794800-48798200 | Weak transcription | Fetal Muscle Trunk | muscle |
25 | chr2:48795000-48796200 | Genic enhancers | Stomach Smooth Muscle | stomach |
26 | chr2:48795200-48796200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
27 | chr2:48795200-48796200 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
28 | chr2:48795200-48796400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
29 | chr2:48795200-48796400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
30 | chr2:48795200-48796400 | Enhancers | Right Atrium | heart |
31 | chr2:48795400-48798200 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
32 | chr2:48795400-48799200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
33 | chr2:48795400-48799400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
34 | chr2:48795400-48799400 | Weak transcription | Brain Hippocampus Middle | brain |
35 | chr2:48795400-48812000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
36 | chr2:48795400-48814200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
37 | chr2:48795600-48796400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
38 | chr2:48795600-48797600 | Weak transcription | Colon Smooth Muscle | Colon |
39 | chr2:48795600-48798600 | Weak transcription | Fetal Heart | heart |
40 | chr2:48795600-48798600 | Weak transcription | HSMMtube | muscle |
41 | chr2:48795600-48800000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
42 | chr2:48795600-48800000 | Weak transcription | Fetal Stomach | stomach |
43 | chr2:48795600-48808000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
44 | chr2:48795600-48826000 | Weak transcription | Fetal Intestine Small | intestine |
45 | chr2:48795800-48799800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
46 | chr2:48795800-48800000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
47 | chr2:48796000-48796200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
48 | chr2:48796000-48796200 | Flanking Active TSS | Adipose Nuclei | Adipose |
49 | chr2:48796000-48796200 | Enhancers | Left Ventricle | heart |
50 | chr2:48796000-48798000 | Weak transcription | Fetal Muscle Leg | muscle |